UTHSC In the Media


Researchers use ‘brain-on-a-chip’ to revolutionize fight against deadly encephalitis viruses

In the Media Icon

A transparent chip no larger than a stick of gum is helping scientists at the University of Tennessee Health Science Center, an R1 research institution, transform the way researchers study the human brain and develop treatments for some of the world’s deadliest viruses.


UT Health Science Center researchers use ‘brain-on-a-chip’ to revolutionize fight against deadly encephalitis viruses

In the Media Icon

A transparent chip no larger than a stick of gum is helping scientists at the University of Tennessee Health Science Center, an R1 research institution, transform the way researchers study the human brain and develop treatments for some of the world’s deadliest viruses.


Dr. Duane D. Miller Selected as Top Professor Emeritus of the Decade by IAOTP

In the Media Icon

The International Association of Top Professionals will honor Dr. Duane D. Miller at their annual red carpet awards gala


Dr. Duane D. Miller Selected as Top Professor Emeritus of the Decade by IAOTP

In the Media Icon

The International Association of Top Professionals will honor Dr. Duane D. Miller at their annual red carpet awards gala


Dr. Duane D. Miller Selected as Top Professor Emeritus of the Decade by IAOTP

In the Media Icon

The International Association of Top Professionals will honor Dr. Duane D. Miller at their annual red carpet awards gala


WKNO Daily Newscast | Tuesday, December 2, 2025

In the Media Icon

A team at the University of Tennessee Health Science Center is using a revolutionary method to study certain viruses, which could lead to the ability to test for diseases that affect the brain.


Erlanger Family Medicine Expands, Welcomes 4 New Providers

In the Media Icon

Erlanger Family Medicine welcomes Sierra Armbrust, DO; Christian Givens, MD; Lindsay Markle Moore, MD; and Ethan Zimmerman, MD, to its team of family medicine providers.


Trial: mRNA Flu Vaccines More Effective Than Quad

In the Media Icon

An mRNA influenza vaccine was approximately 35% more effective than an inactivated quadrivalent flu vaccine against two different strains, based on new data from a phase 3 randomized trial.